The company
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd, was created in 2016 as a "spin-off" company of the University of Minho.
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd, was created in 2016 as a "spin-off" company of the University of Minho.
The main areas of activity are the development and commercialization of pharmaceutical and cosmetic technologies and analytical techniques for application in biotechnology research.
Specialist in research and development in Biotechnology and Nanotechnology in Health, SOLFARCOS provides consulting and management services to support European projects in the field of Nanomedicine.
Specialist in research and development in Biotechnology and Nanotechnology in Health, SOLFARCOS provides consulting and management services to support European projects in the field of Nanomedicine.
The team
Eugénia Nogueira is the main researcher of the Pharmaceutical Line and aggregates the title of SOLFARCOS' CEO and co-founder. She holds a degree and a Master in Biochemistry by the University of Porto, Portugal, and she is a Doctor in Molecular and Environmental Biology by the University of Minho, Portugal. Her research is focused on the development of targeted liposomes for the treatment of inflammatory diseases, as part of 2 European consortia funded by the European Commission's FP7 and H2020 frameworks. She is the author/co-author of 18 scientific articles, 1 book chapter and the co-inventor of 1 patent.
Artur Cavaco-Paulo is the co-founder of SOLFARCOS where he holds the position of CSO. He is Professor at the Department of Biological Engineering of the University of Minho, Portugal, and Honorary Visiting Professor [Changjiang Scholar] at Jiangnan University, China. He is the leader of BBRG group at the Centre of Biological Engineering, Portugal, with ca. 350 publications covering research in the fields of nano and microformulations for pharmacological and cosmetic applications, fibres and polymers bioprocesses for industry, biocatalysis/enzymology, mechanisms of hair colour and shape modulation, molecular dynamics simulations of biological interfaces. As Principal Investigator, he has participated in 21 funded projects and is the co-inventor of 17 patents.
Madalena Martins holds a degree in Chemistry, is Master in Textil Chemistry and Doctor in Chemical and Biological Engineering by the University of Minho, Portugal. Her research is focused on the development of highly stable protein formulations and in the design of new cosmetic and pharmaceutical products for skin and hair treatments. She is the author/co-author of 17 scientific articles, 1 book chapter and the co-inventor of 1 patent.